Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Résultat de la recherche
1 recherche sur le mot-clé 'Autism Asperger-syndrome Pervasive-developmental-disorder Medication Health-disparity'
Affiner la recherche Générer le flux rss de la recherche
Partager le résultat de cette recherche Faire une suggestion
Psychotropic Medication Use Among Children With Autism Spectrum Disorders Enrolled in a National Registry, 2007–2008 / Rebecca E. ROSENBERG in Journal of Autism and Developmental Disorders, 40-3 (March 2010)
[article]
Titre : Psychotropic Medication Use Among Children With Autism Spectrum Disorders Enrolled in a National Registry, 2007–2008 Type de document : Texte imprimé et/ou numérique Auteurs : Rebecca E. ROSENBERG, Auteur ; Alison MARVIN, Auteur ; David S. MANDELL, Auteur ; J. Kiely LAW, Auteur ; Paul A. LAW, Auteur ; Janet E. FARMER, Auteur Année de publication : 2010 Article en page(s) : p.342-351 Langues : Anglais (eng) Mots-clés : Autism Asperger-syndrome Pervasive-developmental-disorder Medication Health-disparity Index. décimale : PER Périodiques Résumé : Patterns of current psychotropic medication use among 5,181 children with autism spectrum disorders (ASD) enrolled in a Web-based registry were examined. Overall, 35% used at least one psychotropic medication, most commonly stimulants, neuroleptics, and/or antidepressants. Those who were uninsured or exclusively privately insured were less likely to use ≥3 medications than were those insured by Medicaid. Psychiatrists and neurologists prescribed the majority of psychotropic medications. In multivariate analysis, older age, presence of intellectual disability or psychiatric comorbidity, and residing in a poorer county or in the South or Midwest regions of the United States increased the odds of psychotropic medication use. Factors external to clinical presentation likely affect odds of psychotropic medication use among children with ASD. En ligne : http://dx.doi.org/10.1007/s10803-009-0878-1 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=966
in Journal of Autism and Developmental Disorders > 40-3 (March 2010) . - p.342-351[article] Psychotropic Medication Use Among Children With Autism Spectrum Disorders Enrolled in a National Registry, 2007–2008 [Texte imprimé et/ou numérique] / Rebecca E. ROSENBERG, Auteur ; Alison MARVIN, Auteur ; David S. MANDELL, Auteur ; J. Kiely LAW, Auteur ; Paul A. LAW, Auteur ; Janet E. FARMER, Auteur . - 2010 . - p.342-351.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 40-3 (March 2010) . - p.342-351
Mots-clés : Autism Asperger-syndrome Pervasive-developmental-disorder Medication Health-disparity Index. décimale : PER Périodiques Résumé : Patterns of current psychotropic medication use among 5,181 children with autism spectrum disorders (ASD) enrolled in a Web-based registry were examined. Overall, 35% used at least one psychotropic medication, most commonly stimulants, neuroleptics, and/or antidepressants. Those who were uninsured or exclusively privately insured were less likely to use ≥3 medications than were those insured by Medicaid. Psychiatrists and neurologists prescribed the majority of psychotropic medications. In multivariate analysis, older age, presence of intellectual disability or psychiatric comorbidity, and residing in a poorer county or in the South or Midwest regions of the United States increased the odds of psychotropic medication use. Factors external to clinical presentation likely affect odds of psychotropic medication use among children with ASD. En ligne : http://dx.doi.org/10.1007/s10803-009-0878-1 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=966